About the LCTU
Clinical Trials
- Haematology
  - CLL210
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - PACIFICO
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - RIAltO
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - UK CLL Trials Biobank
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Head and Neck
  - Dahanca-21
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - HOPON
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - REALISTIC
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - TITAN
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Liver
- Lung
  - UKLS
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Melanoma
  - ITEM
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - NITRO
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - SUAVE
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Other
  - BIOPROP
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - MERCK PN114
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Palliative Care
  - ChemdEL
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - Demoralisation
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - INPIC
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Pancreas
  - ESPAC-1
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - ESPAC-3/ESPAC-3(v2)
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - ESPAC-4
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - EUROPAC2
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - GEMCAP
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - PETPANC
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - TeloVac
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
  - VIP
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Translational
  - ESPAC-Tplus
    - Information
    - Treatment
    - Endpoints
    - Eligibility
    - Sites - Open
    - Sites - Interested
    - Map of Sites
    - FAQ
    - Links
- Urology
Patient Information
Regulatory Information
Useful Links
Latest News

Sites - Interested

GERMANY (ordered by Town then hospital name)

04103 Leipzig, Universitatsklinikum Leipzig (Prof. Dr. Joachim Mössner)
44791 Bochum, St. Josef Hospital (Bochum) (Prof. Dr. med. Waldemar Uhl)
D-81675 Munchen, Klinikum Rechts Der Isar Der Tu Munchen (Prof. Dr. Jorg Kleeff)

INDIA (ordered by Town then hospital name)

Mumbai-400012, Tata Memorial Centre (Mumbai) (Dr. Bhawna Sirohi)

ITALY (ordered by Town then hospital name)

Bologna, Bologna University (Dr. Cristina Di Marco)

SWEDEN (ordered by Town then hospital name)

413 45 Göteborg, Sahlgrenska Universitetssjukhusetmore (Goteborg) (Dr. Tor Ekman)

UK: ENGLAND (ordered by Town then hospital name)

Burton-upon-Trent, Queen's Hospital (Burton-upon-Trent) (Dr. Kate Shankland)
Cottingham, Castle Hill Hospital (Cottingham) (Dr. Anthony Maraveyas)
Portsmouth, Queen Alexandra Hospital (Portsmouth) (Dr. Caroline Archer)
York, York Hospital (Dr. Kim Last)

UK: N. IRELAND (ordered by Town then hospital name)

Belfast, Belfast City Hospital (Dr. Martin Eatock)

UK: SCOTLAND (ordered by Town then hospital name)

Dundee, Tayside Cancer Centre (Dundee) (Dr. Douglas Adamson)

UK: WALES (ordered by Town then hospital name)

Wrexham, Wrexham Maelor Hospital (Dr. Simon Gollins)

Admin/Site Area

Username:
Password:

Forgotten Password

People and Partners

Latest Job Vacancies

Sorry there are currently no job vacancies

Quick Links

Useful Links:

Useful Downloads

Some useful downloads:

Research Networks

"The experience and treatment I received at the Royal Liverpool Hospital was so fantastic that I had to tell the people involved with my treatment how marvelous they were, so please would you pass on my thanks and gratitude to Professor Neoptolemos and his team of surgeons, the wonderful doctors and nursing staff" - Anon (Participant in ESPAC-3(v2) trial)